Mayo Clinic today announced the launch of Mayo Clinic Platform_Orchestrate, a new program designed to accelerate clinical development and help biopharma and medical device companies bring innovative therapies to patients faster.
Mayo Clinic Platform_Orchestrate gives collaborators a single point of access to Mayo Clinic's world-class research and clinical expertise, de-identified clinical data, advanced artificial intelligence (AI) tools, physician-scientist expertise and international partner network. By removing barriers that traditionally slow clinical development, the program enables companies to move efficiently from discovery to delivery.
"Mayo Clinic Platform_Orchestrate was created to help our life sciences and biopharma partners bring therapies to patients safely and faster," says Maneesh Goyal, chief operating officer, Mayo Clinic Platform. "By combining trusted data, advanced AI and Mayo Clinic's scientific expertise, we are reimagining what's possible in clinical development."
How it works
Within Mayo Clinic Platform's ecosystem of clinical data, AI and clinician expertise, Mayo Clinic Platform_Orchestrate serves as the front door for collaboration. The program streamlines access to:
- Discovery - access to real-world clinical data and biospecimens.
- Validation - rigorous testing and refinement of AI models and digital solutions.
- Deployment - scalable infrastructure to integrate innovations across Mayo Clinic and its international network.
Through this streamlined entry point, companies can:
- Accelerate product pipelines with access to de-identified, multi-modal longitudinal clinical data (powered by nference) across Mayo Clinic Platform's growing global network.
- Advance AI innovation by building, validating and deploying clinically useful solutions.
- Drive discovery with Mayo Clinic's biospecimens, multi-omics profiling and physician-scientist expertise.
- Scale solutions through Mayo Clinic's U.S. and international partner ecosystem.
Leading life sciences and technology firms are already using the Mayo Clinic Platform_Orchestrate program, underscoring strong industry demand for its capabilities. Early projects are harnessing the platform to develop multimodal AI models for early disease detection, create tools that precisely identify patients for targeted therapies, accelerate and diversify clinical trial recruitment, and deploy validated digital health solutions at scale across U.S. and international care settings. These collaborations highlight how Mayo Clinic Platform_Orchestrate is rapidly moving innovation from concept to practice.
